Header image

HSANZ Free Communications 1: Acute Leukaemia

Tracks
HSANZ
Monday, November 6, 2023
8:30 AM - 10:00 AM
Plenary 3

Details

Kindly sponsored by Jazz Pharmaceuticals


Speaker

Mr Basit Salik
PhD Candidate
QIMR Berghofer

Harnessing the stress response for immunity in acute myeloid leukaemia

8:30 AM - 8:45 AM

Biography

Basit Salik is a PhD candidate at QIMR Berghofer/University of Queensland supported by the Leukaemia Foundation/HSANZ new investigator scholarship.
Assoc Prof Matthew Greenwood
Haematologist
Royal North Shore Hospital

Blinatumomab in combination with an intensive paediatric protocol results in high rates of end-consolidation MRD negativity – update of the Australasian Leukaemia and Lymphoma Group (ALLG) ALL09 "SUBLIME” Study

8:45 AM - 9:00 AM

Biography

A/Prof Matthew Greenwood is Director of Stem Cell Transplantation at Royal North Shore Hospital in Sydney. He is currently co-chair of the Acute Leukaemia Working Party of the Australasian Leukaemia and Lymphoma Group (ALLG) and a lead investigator on the ALLG ALL06 and ALL09 studies in AYA ALL.
Ms Jacqueline Rehn
PhD Candidate
South Australian Health and Medical Research Institute

High expression of DUX4 mRNA is a reliable indicator of DUX4-rearranged acute lymphoblastic leukaemia

9:00 AM - 9:15 AM

Biography

Jacqueline is a final year PhD candidate with the University of Adelaide and the South Australian Health and Medical Research Institute. Her research focuses on the investigation of bioinformatics methods for improved detection of genomic alterations from transcriptomic data for patients with acute lymphoblastic leukaemia.
Dr Yin Yuan
PhD Candidate
Walter and Eliza Hall Institute

STING agonists exert a direct anti-leukaemic effect in AML via induction of apoptosis

9:15 AM - 9:30 AM

Biography

Dr Yin Yuan completed her clinical and laboratory haematology training in Queensland. She is currently undertaking a PhD at the Walter and Eliza Hall Institute of Medical Research conducting pre-clinical evaluation of novel agents in AML. Her PhD is supported by an NHMRC Postgraduate Scholarship and RCPA Postgraduate Research Fellowship.
Assoc Prof Shaun Fleming
Head of Myeloid Diseases Service
Alfred Health

Blinatumomab with Reduced Intensity Chemotherapy for Older Adults with Newly Diagnosed Ph negative B-Precursor Acute Lymphoblastic Leukemia – Final Results of the ALLG ALL08 Study

9:30 AM - 9:45 AM

Biography

Associate Professor Fleming is the head of the myeloid diseases service at the Alfred Hospital in Melbourne. He is an active investigator in clinical trials in Acute Leukaemia with a focus on novel therapies and novel prognostication strategies including machine learning.
Dr Sean Harrop
Haematology Registrar
Peter MacCallum Cancer Centre

Novel clinicogenomic findings in the emerging entity of acute myeloid leukaemia with UBTF tandem duplications

9:45 AM - 10:00 AM

Biography

Dr. Sean Harrop is a final year haematology advanced trainee at the Peter MacCallum Cancer Centre.

Chairperson

Christina Brown
Haematologist
Royal Prince Alfred Hospital

Edward Chew
Haematologist
The Royal Melbourne Hospital

loading